These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37508201)

  • 61. Methicillin-resistant Staphylococcus aureus bloodstream infections are associated with a higher energy deficit than other ICU-acquired bacteremia.
    Ekpe K; Novara A; Mainardi JL; Fagon JY; Faisy C
    Intensive Care Med; 2014 Dec; 40(12):1878-87. PubMed ID: 25288210
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
    Chopra T; Marchaim D; Awali RA; Krishna A; Johnson P; Tansek R; Chaudary K; Lephart P; Slim J; Hothi J; Ahmed H; Pogue JM; Zhao JJ; Kaye KS
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6270-5. PubMed ID: 24100492
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multidrug-resistant bacteria in urine culture among patients with spinal cord injury and disorder: Time to first detection and analysis of risk factors.
    Šámal V; Paldus V; Fáčková D; Mečl J
    Spinal Cord; 2022 Aug; 60(8):733-738. PubMed ID: 35197573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal.
    Garrouste-Orgeas M; Timsit JF; Tafflet M; Misset B; Zahar JR; Soufir L; Lazard T; Jamali S; Mourvillier B; Cohen Y; De Lassence A; Azoulay E; Cheval C; Descorps-Declere A; Adrie C; Costa de Beauregard MA; Carlet J;
    Clin Infect Dis; 2006 Apr; 42(8):1118-26. PubMed ID: 16575729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic.
    Torrecillas M; Gumucio VD; Padullés A; Tubau F; Marco D; Shaw E; Fernández-Huerta M; Maisterra K; Grau I; Petito MM; Berbel D; Puig-Asensio M; Pérez XL; Domínguez MÁ; Sabater J; Ardanuy C; Càmara J
    Infect Prev Pract; 2022 Dec; 4(4):100241. PubMed ID: 36061570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections.
    Li YY; Chen Y; Li S; Li YY; An R; Hu XY; Jiang W; Wang CY; Dong R; Yang QW; Weng L; Peng JM; Du B
    Infect Dis Ther; 2024 Apr; 13(4):861-874. PubMed ID: 38536646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The impact of ageing on the incidence and mortality rate of bloodstream infection: A hospital-based case-cohort study in a tertiary public hospital of Brazil.
    da Silva NCZ; da Rocha JA; do Valle FM; Silva ASDN; Ehrlich S; Martins IS
    Trop Med Int Health; 2021 Oct; 26(10):1276-1284. PubMed ID: 34218504
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study.
    Hu Y; Li D; Xu L; Hu Y; Sang Y; Zhang G; Dai H
    Antimicrob Resist Infect Control; 2021 Jun; 10(1):98. PubMed ID: 34193300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multidrug-Resistant Bacteria on Healthcare Workers' Uniforms in Hospitals and Long-Term Care Facilities in Cyprus.
    Lena P; Karageorgos SA; Loutsiou P; Poupazi A; Lamnisos D; Papageorgis P; Tsioutis C
    Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052926
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk Factors for a Hospital-Acquired Carbapenem-Resistant
    Cao Z; Yue C; Kong Q; Liu Y; Li J
    Infect Drug Resist; 2022; 15():641-654. PubMed ID: 35241916
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.
    Ahmed SH; Daef EA; Badary MS; Mahmoud MA; Abd-Elsayed AA
    BMC Res Notes; 2009 May; 2():76. PubMed ID: 19419535
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
    Segala FV; Pafundi PC; Masciocchi C; Fiori B; Taddei E; Antenucci L; De Angelis G; Guerriero S; Pastorino R; Damiani A; Posteraro B; Sanguinetti M; De Pascale G; Fantoni M; Murri R
    Infection; 2023 Aug; 51(4):1061-1069. PubMed ID: 36867310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB; Lee H; Gregson DB; Manns BJ
    J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Retrospective Analysis of Risk Factors and Patient Outcomes of Bloodstream Infection with Extended-Spectrum β-Lactamase-Producing
    Xiao Y; Hang Y; Chen Y; Fang X; Cao X; Hu X; Luo H; Zhu H; Zhu W; Zhong Q; Hu L
    Infect Drug Resist; 2020; 13():4289-4296. PubMed ID: 33262623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.
    Seguin P; Fédun Y; Laviolle B; Nesseler N; Donnio PY; Mallédant Y
    J Antimicrob Chemother; 2010 Feb; 65(2):342-6. PubMed ID: 20008043
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of bloodstream infection on survival in COVID-19 patients admitted to an intensive care unit in Colombia: a matched cohort analysis.
    Cortes JA; Valderrama-Rios MC; Nocua-Báez LC; Quitián LM; Lozada FA; Buitrago G
    Infect Prev Pract; 2023 Jun; 5(2):100283. PubMed ID: 37197192
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hospital-Acquired Infections in Critically Ill Patients With COVID-19.
    Grasselli G; Scaravilli V; Mangioni D; Scudeller L; Alagna L; Bartoletti M; Bellani G; Biagioni E; Bonfanti P; Bottino N; Coloretti I; Cutuli SL; De Pascale G; Ferlicca D; Fior G; Forastieri A; Franzetti M; Greco M; Guzzardella A; Linguadoca S; Meschiari M; Messina A; Monti G; Morelli P; Muscatello A; Redaelli S; Stefanini F; Tonetti T; Antonelli M; Cecconi M; Foti G; Fumagalli R; Girardis M; Ranieri M; Viale P; Raviglione M; Pesenti A; Gori A; Bandera A
    Chest; 2021 Aug; 160(2):454-465. PubMed ID: 33857475
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study).
    Gonçalves-Pereira J; Povoa PR; Lobo C; Carneiro AH
    Clin Microbiol Infect; 2013 Mar; 19(3):242-8. PubMed ID: 22360358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospital.
    Ramos R; de la Villa S; García-Ramos S; Padilla B; García-Olivares P; Piñero P; Garrido A; Hortal J; Muñoz P; Caamaño E; Benito P; Cedeño J; Garutti I;
    Enferm Infecc Microbiol Clin; 2023 May; 41(5):278-283. PubMed ID: 34908639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.